Secular erosion of the .com/.net domain base + regulatory caps on the price lever the whole thesis rides on
One-line thesis. VeriSign is one of the highest-quality business models in the S&P 500 — a government-sanctioned near-monopoly on .com/.net with 88% gross margins, 50% net margins and 100% pricing discipline — but it grows revenue only ~6-7% a year, the stock already trades at ~28× earnings, and the price lever is regulated; a wonderful business at a full-ish price with no expert-panel edge, which lands it a Watch, not a Buy.
◆ Synthos call — WatchVRSN is a business we want at a price we don't have — it becomes a Buy below ~$233; until then, do nothing.
Downside Risk (lower = safer)
5/10 · Moderate
Low beta (0.69) & 1.1× net-debt/EBITDA, but 28× trailing on ~6% growth, negative book equity, and .com price/renewal regulatory overhang.
Growth Quality
6/10 · High
Elite 88% gross / 50% net margins & near-monopoly moat, but only ~6-7% forward revenue CAGR; EPS CAGR ~12% is buyback-levered, not organic.
Exponential Potential
2/10 · Low
A durable toll-booth utility, not an exponential — ~6% revenue growth and decelerating, regulated pricing, near-zero room-to-run optionality.
⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 13%/yrTo justify today’s $256, earnings would have to compound roughly 13% a year for 10 years (9% discount rate). Analysts forecast ~12%/yr, so the market is pricing in about what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
VeriSign runs the "phone book" for the two biggest chunks of the internet: every website ending in .com and .net pays VeriSign a small annual fee, and VeriSign is the only company legally allowed to run them. That makes it a toll booth — it collects a little money from hundreds of millions of web addresses, keeps about 50 cents of every dollar as pure profit, and barely has to spend anything to do it. Warren Buffett's Berkshire Hathaway has famously owned it for years for exactly this reason.
The catch: it's a slow-growing toll booth. The number of .com/.net names only grows a few percent a year, and the government contract limits how fast VeriSign can raise its prices. So the business is superb but the growth is modest — and the stock isn't cheap enough to make up for that. Our verdict is Watch: a great company, near a fair price, that you'd want to buy on a real pullback rather than here.
Here's what our three scores mean in everyday terms:
Downside Risk 5/10 (middle). Very steady, low-drama business with little debt and a calm stock — but it's priced at a premium for something that grows slowly, so there's little cushion if growth stalls.
Growth Quality 6/10 (good, not great). Fantastically profitable and protected, but the top line only grows ~6-7%; the faster-growing per-share earnings come partly from buying back stock, not from the business itself.
Exponential Potential 2/10 (low). This is a steady utility, not a rocket. Don't expect it to multiply.
The one big worry: the whole story depends on people keeping (and renewing) .com/.net names and on the government letting VeriSign nudge prices up. If AI changes how we find websites, or regulators freeze pricing, the toll booth's growth could stall.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLK (sector)), set to 100 a year ago
Solid = VRSN · dashed = S&P 500 · dotted = XLK (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$256.43
Market cap$23B
P/E trailing11×
P/E FY26E / FY27E26× / 24×
EV / Sales14.6×
EV / EBITDA20.7×
Gross margin88.3%
Net margin50.0%
Dividend yield1.23%
Beta0.688
52-wk range$211 – $310
RSI(14)29
50 / 200-DMA$279 / $257
12-mo return+-11% (SPY +21%)
Street target$355 ($355–$355)
Analyst grades8 Buy · 5 Hold · 1 Sell
FMP ratingB-
Next earnings2026-08-05
What the experts actually said 0 traceable claims on VRSN · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
VeriSign (NASDAQ: VRSN) operates the authoritative registry for the .com and .net top-level domains under long-standing agreements with ICANN and the U.S. Department of Commerce. It is, in effect, critical internet infrastructure: it operates two of the world's thirteen root servers, serves as Root Zone Maintainer, and guarantees resolution for .com/.net — a record it notes is now in its 29th year of 100% .com/.net resolution availability. It also runs the back-end for .cc, .gov, .edu and .name. Fiscal year ends December 31. Founded 1995, HQ Reston, VA; just 929 employees run a $1.66B-revenue franchise — the tell of an extraordinarily lean, automated business.
The model is a per-name annual fee: VeriSign charges registrars a wholesale fee (rising from $10.26 to $10.97 per .com name effective Nov 1, 2026), multiplied across the domain base. Two variables drive everything: (1) the domain-name base (176.1M .com/.net names at Q1'26, +3.7% YoY, +2.54M net in the quarter), and (2) the regulated wholesale price (contractually capped increases). Growth = base growth × allowed price increases. That is the entire engine.
Revenue mix (FY2025, from FMP segmentation):
By type: FMP provides no product-level split — VeriSign is effectively a single-product registry (.com/.net fees).
By geography: United States $1,093M (66%) · EMEA $279M (17%) · Asia Pacific $185M (11%) · Other $100M (6%). US-concentrated, but the "product" is global internet addressing, so geographic mix matters less than the domain-base trend.
2. The expert thesis (no coverage — stated plainly)
There is zero expert coverage of VRSN in the Synthos knowledge base: total_claims = 0, breadth 0, net conviction 0. No net-bullish voices, no cautionary voice, nothing to reconcile. Per the House Standard, we will not fabricate conviction we do not have.
What this means for the verdict: this note is entirely fundamentals- and quant-driven. There is no independent expert panel pushing us off the numbers in either direction, so the scores, the scenario model and the valuation below carry the full weight of the call. Read them as exactly that: a disciplined read of the financials and the market data, not a distillation of outside conviction. The absence of coverage is itself mildly informative — VRSN is a well-understood, slow-moving utility that generates little debate among the high-signal voices Synthos tracks.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
5 · Moderate
Beta 0.69, net-debt/EBITDA 1.1×, minimal capex and a 4.5% FCF yield make it sturdy — but 28× trailing on ~6% growth, negative book equity (buyback-driven), and a regulated price lever cap the margin of safety.
Growth Quality
6 · Good
88% gross / 68% operating / 50% net margins and a near-monopoly moat are elite; but ~6-7% forward revenue CAGR is pedestrian, and the ~12% EPS CAGR leans on buybacks, not organic expansion.
Exponential Potential
2 · Low
A regulated toll-booth utility. Revenue growth is single-digit and decelerating, pricing is contractually capped, and there is no adjacent-TAM optionality. Steady, not exponential.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores above summarize them.
Case
Key assumptions
Fair value
Bull
Domain base reaccelerates toward ~4-5%; Nov-2026 and future .com price hikes flow through; buybacks shrink the share count faster. FY27E EPS beats to ~$11.30 (vs $10.91 cons); multiple re-rates to a premium ~28×.
~$316 (+23%)
Base(our anchor)
Estimates roughly hit — FY27E EPS $10.91; a durable ~6-7% grower with a monopoly moat earns a ~24× multiple (its own historical mid-range).
~$265 (+3%)
Bear
Domain base flattens/declines (AI-era navigation erosion, weak renewals); regulatory friction on .com pricing; multiple de-rates to ~18× on FY27E EPS ~$10.30.
~$185 (−28%)
Synthos fair value = the base case, ~$265 (+3%), with the full $185–$316 span as the honest range. Note our base sits well below the Street's $355 — that consensus reads as a single-source target (high, low and median are all identically $355), so we weight it lightly and anchor on our own ~24× FY27E model. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). VRSN is a high-quality utility that is neither accelerating nor multi-bagging:
Forward growth: revenue CAGR FY25→FY28E ~6.5% ($1.66B → $2.00B); EPS CAGR ~11.8% ($8.83 → $12.35) — but the gap between the two is buybacks (share count fell from 115M in 2020 to ~91.6M in Q1'26), not organic acceleration.
Acceleration (the 2nd derivative) is flat-to-negative: revenue grew +6.4% (FY25) and estimates imply +5.4% (FY26E) → +7.2% (FY27E) → +7.0% (FY28E) — a steady single-digit band, not an inflection. The domain base itself grows ~3-4%; the rest is price.
Room to run: the "TAM" is the finite universe of .com/.net registrations. There is no new market to conquer, no product adjacency, no platform optionality. At $23B the cap is modest, but the addressable growth is the binding constraint, not size.
Reinvestment runway: essentially none needed — capex is only ~1.4% of revenue. That is wonderful for FCF conversion but is the opposite of a reinvestment-driven compounder; excess cash goes to buybacks and a dividend.
Exponential Potential: Low (2/10). Own VRSN for what it is — a bond-like toll booth with pricing power and elite margins — not for growth. Nothing here supports a multibagger thesis, and honesty requires scoring it as such rather than defaulting to a middling 5.
Quarterly trajectory: Q1'25 $402.3M → Q2 $409.9M → Q3 $419.1M → Q4 $425.3M → Q1'26 $428.9M (+6.6% YoY). A metronome — the appeal and the limit in one line.
Margins: gross 88.3% TTM, operating ~68%, net 50.0% TTM. Among the highest margin structures in the entire S&P 500 — the signature of a monopoly with almost no cost of goods.
Earnings: net income $825.7M FY25 (+5.1% on FY24 $785.7M); diluted EPS $8.81 (FY24 $8.00). Q1'26 net income $214.5M, diluted EPS $2.34.
Cash flow: operating CF $1,091M, capex only −$22.8M, FCF $1,068M FY25 — ~98% FCF/OCF conversion. FCF yield ~4.5%. Nearly all of it returned via $893M buybacks + $215M dividends in FY25.
Balance sheet: total debt $1.80B, net debt $1.49B, net-debt/EBITDA 1.1× — easily serviceable against ~$1.17B EBITDA (interest coverage ~15×). Note the negative book equity (−$2.15B): this is not distress — it is the accounting scar of years of buybacks exceeding retained earnings, a common feature of cash-machine compounders. Judge it on FCF and coverage, not book value.
6. Valuation — priced in or room?
VRSN is not cheap and not egregious — it trades roughly in line with its own history for a monopoly utility. 28× trailing EPS, 26× FY26E, 24× FY27E, 21× FY28E; EV/EBITDA 20.6×, EV/Sales 14.6×. The FMP PEG of ~2.6× is elevated because growth is slow, not because the multiple is crazy. The bull's defense is quality (monopoly, 50% margins, 4.5% FCF yield, relentless buybacks); the bear's is that you are paying 24-28× for ~6% revenue growth with a regulated ceiling on the one real price lever. A ~24× FY27E multiple (its own mid-range) on $10.91 gets you ~$262, essentially today's price — i.e. the market has it about right. Street target (context): $355, but with high = low = median = $355 this is effectively a single analyst's number and we treat it as thin, not as our anchor. Net: fairly valued, which is precisely why the verdict is Watch, not Buy — there is no discount here to underwrite.
7. Technicals (from the FMP tech block)
Trend:down/basing. $256 sits below the 50-DMA ($279) and roughly at the 200-DMA ($257) — a stock that has lost its uptrend and is trying to find a floor at long-term support. MACD −9.0 (negative).
Location:−17.3% off the 52-week high ($310), +21% off the 52-week low ($211); max drawdown from peak −17.3%. Well off highs, mid-range.
Momentum: RSI(14) 28.8 — oversold (<30). A washed-out reading that often precedes a bounce, but on its own is not a buy signal.
Relative strength (the tell): VRSN −11.3% 12-mo vs SPY +20.6% and QQQ +30.3% — dramatic underperformance of both the market and the Nasdaq. It also lags on 3-mo (+2.3% vs SPY +13.7%) and 6-mo. This is a laggard, not a leader.
Read: technicals do not confirm a bullish thesis — they show a defensive name that has de-rated and is testing its 200-DMA. The oversold RSI plus 200-DMA support is the setup a patient buyer would watch for a better entry, consistent with the Watch verdict.
8. Moat & competitive position
VeriSign has arguably the cleanest moat in the S&P 500: a contractual, government-sanctioned monopoly on .com and .net, the two most valuable top-level domains, with switching costs that are effectively infinite (a business cannot casually abandon its .com). The barriers are legal and infrastructural, not competitive — no rival can simply decide to run .com. 100% resolution uptime for 29 years, two root servers, and a 75% .com/.net renewal rate underline the durability. The flip side is that the same contract caps pricing power and invites regulatory/political scrutiny of every price increase.
Peer set (FMP, market cap): the FMP peer list is loose — Affirm $28B, Corpay $23B, Flex $50B, GoDaddy $12B, Gen Digital $16B, Samsara $21B, PTC $14B, SS&C $16B, Check Point $14B, Toast $17B. Only GoDaddy (domains/hosting, downstream registrar) is a genuine business comparable, and even that is a customer-side, not a registry, peer. VRSN has no true public comp — its combination of monopoly registry economics and 50% net margins is unique in the group.
9. Management, capital allocation & guidance
Capital allocation: textbook cash-return discipline. FY25 returned $893M in buybacks + $215M in dividends (dividend initiated 2024; $0.81/quarter as of the Q1'26 release, ~1.2% yield), with $863M remaining on the repurchase authorization. Minimal capex, no empire-building M&A. This is a shareholder-yield machine, not a reinvestment story.
Insider activity: the sampled window shows consistent, routine selling by Exec Chairman/CEO Jim Bidzos (multiple small Form-4 S-Sale lots at $246–$252 through late June / early July 2026) plus a small sale by the General Counsel. These read as programmatic/diversification sales rather than a discretionary red flag, but the net insider posture is selling, not buying — worth noting, not alarming.
Management's own guidance (half-weighted, self-interested): the SEC 8-K (Item 2.02) Q1'26 earnings release (filed 2026-04-23) is a real earnings release (revenue, income, domain-base metrics, pricing). Management's own dated, forward-looking disclosures: revenue $429M (+6.6% YoY), diluted EPS $2.34; domain base 176.1M (+3.7% YoY), +2.54M net adds; 11.5M new registrations (vs 10.1M a year prior); Q4'25 final .com/.net renewal rate 75.0% (up from 74.0%); and the headline lever — a .com wholesale fee increase from $10.26 to $10.97 effective Nov 1, 2026. Management framed the quarter as "steady growth in registrations and solid financial results." Treat as management's own book, half-weighted — but note the release contained operating metrics, not explicit full-year financial guidance, so there is no formal revenue/EPS outlook to relay.
10. Catalysts & what to watch
Next earnings: 2026-07-23 (Q2'26; Street EPS $2.39, revenue ~$434M). The key lines: domain-base net adds and the renewal rate — the two numbers that actually move the thesis.
Nov 1, 2026 .com price increase ($10.26 → $10.97): the primary near-term revenue lever; watch that it flows through without registrar/regulatory pushback.
Domain-base trajectory: any sign of the base shrinking (weak new registrations, falling renewals) would break the base case.
Regulatory / ICANN / DoC: any change to the .com Registry Agreement pricing provisions is a structural swing factor.
AI-era navigation: early evidence on whether AI agents/answers erode the economic need to register .com/.net names — a slow-burn secular question, not a quarter-to-quarter one.
Thesis tripwires (what would change the call): a declining domain base for two consecutive quarters; a renewal rate falling below ~73%; a regulatory freeze/rollback of .com pricing; or the multiple re-rating above ~28× without a growth re-acceleration (would flip us toward trimming).
11. Key risks
Secular domain-base erosion (structural): the entire model rides on the .com/.net base growing (or at least holding). Weak new registrations, a maturing internet, and the open question of whether AI changes how people/agents navigate the web are real long-term threats.
Regulated pricing (structural): VeriSign cannot freely raise prices — increases are contractually capped and politically scrutinized. The one clean lever is not fully in management's control.
Valuation / no margin of safety: 28× trailing on ~6% growth leaves little room; a de-rating toward 18-20× (as the technicals already hint) is the bear path.
Concentration / single-product: essentially one product (.com/.net fees). No diversification cushion if that stream is impaired.
Negative book equity optics: harmless in reality (buyback artifact) but can spook screens and covenants; worth understanding, not fearing.
No expert edge: unlike higher-conviction names, there is no Synthos expert panel here — the call rests entirely on the numbers, which raises the burden on our own model being right.
12. Verdict, position sizing & monitoring
Watch. VeriSign is a genuinely elite business — a government-sanctioned .com/.net monopoly with 88% gross margins, 50% net margins, ~98% FCF conversion and a fortress-like moat — trading at a fair-to-full ~24-28× multiple on ~6% revenue growth, with a regulated price lever and no expert-panel conviction to lean on. Our base-case fair value (~$265) is barely above today's price, the Street's $355 target looks like a single thin source, and the technicals show a laggard testing its 200-DMA. That combination — wonderful company, unremarkable growth, no discount, no edge — is the textbook definition of a Watch, not a Buy.
Sizing: if already owned as a low-beta, bond-proxy holding, a small ~1-3% sleeve is defensible. For new capital, wait for a better entry — the bear-case ~$185 (18× FY27E) or a domain-base re-acceleration would each justify an upgrade.
Monitoring: re-underwrite on the §10 tripwires; formal re-score at each earnings print (next 2026-07-23). This verdict is logged as a tracked Synthos call as of 2026-07-03 at $256.43.
Single biggest risk: secular erosion of the .com/.net domain base combined with regulatory caps on pricing — the two forces that could quietly turn a 6% grower into a 0% grower.
Provenance & disclosures
Traceability:0 KB claims, breadth 0 — there is no expert coverage of VRSN in the Synthos knowledge base, and this is stated plainly rather than papered over. The verdict is fundamentals- and quant-driven. Fabricated conviction is structurally impossible (claim-ID reconciliation), and here there were simply no claims to cite.
Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · no expert claims. Forward figures are analyst consensus (FMP), labeled as estimates.
Management caveat: the §9 guidance is management's own Q1'26 earnings-release language (SEC 8-K Item 2.02), half-weighted by design; it contained operating metrics, not formal full-year financial guidance.
Street-target caveat: the $355 consensus has identical high/low/median, indicating thin (likely single-source) coverage — treated as context, not an anchor.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").